In the last 12 months, insiders at Pasithea Therapeutics Corp. ($KTTA) filed 40 transactions with the SEC: 4 open-market purchases totaling $162,929 and 1 sales totaling $792. Net insider sentiment: net buying.
Pasithea Therapeutics Corp. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- STEINMAN LAWRENCE (Director) — 6 transactions totaling $112,930
- Marques Tiago (Chief Executive Officer) — 8 transactions totaling $25,792
- Dumesnil Simon (Director) — 5 transactions totaling $25,000
- Leahy Emer (Director) — 5 transactions totaling $25,000
- Schneiderman Daniel H (Chief Financial Officer) — 7 transactions totaling $20,000
View all SEC Filings for Pasithea Therapeutics Corp. (KTTA).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| May 1, 2026 | Marques Tiago | Chief Executive Officer | A | Stock Option (right to buy) | 1756069 | $0.00 | 1,756,069.0000 | 7,031,050 | 9999.99% | 24.98% |
| May 1, 2026 | Novak Alfred J | Director | A | Stock Option (right to buy) | 152783 | $0.00 | 152,783.0000 | 7,031,050 | 9999.99% | 2.17% |
| May 1, 2026 | Leahy Emer | Director | A | Stock Option (right to buy) | 152783 | $0.00 | 152,783.0000 | 7,031,050 | 9999.99% | 2.17% |
| May 1, 2026 | Krishnan Kartik | Chief Medical Officer | A | Stock Option (right to buy) | 1129323 | $0.00 | 1,129,323.0000 | 7,031,050 | 9999.99% | 16.06% |
| May 1, 2026 | Schneiderman Daniel H | Chief Financial Officer | A | Stock Option (right to buy) | 1129323 | $0.00 | 1,129,323.0000 | 7,031,050 | 9999.99% | 16.06% |
| May 1, 2026 | Dumesnil Simon | Director | A | Stock Option (right to buy) | 152783 | $0.00 | 152,783.0000 | 7,031,050 | 9999.99% | 2.17% |
| May 1, 2026 | STEINMAN LAWRENCE | Director | A | Stock Option (right to buy) | 152783 | $0.00 | 152,783.0000 | 7,031,050 | 9999.99% | 2.17% |
| Nov. 28, 2025 | Leahy Emer | Director | A | Common Stock | 33333 | $0.75 | 33,333.0000 | 7,443,577 | 9999.99% | 0.45% |
| Nov. 28, 2025 | STEINMAN LAWRENCE | Director | P | Common Stock | 133333 | $0.75 | 199,691.0000 | 7,443,577 | 200.93% | 1.79% |
| Nov. 28, 2025 | Schneiderman Daniel H | Chief Financial Officer | A | Common Stock | 26667 | $0.75 | 26,667.0000 | 7,443,577 | 9999.99% | 0.36% |
| Nov. 28, 2025 | Marques Tiago | Chief Executive Officer | P | Common Stock | 33333 | $0.75 | 73,334.0000 | 7,443,577 | 83.33% | 0.45% |
| Nov. 28, 2025 | Dumesnil Simon | Director | P | Common Stock | 33333 | $0.75 | 35,833.0000 | 7,443,577 | 1333.32% | 0.45% |
| Oct. 24, 2025 | Dumesnil Simon | Director | A | Stock Option (right to buy) | 42913 | $0.00 | 42,913.0000 | 7,443,577 | 9999.99% | 0.58% |
| Oct. 24, 2025 | STEINMAN LAWRENCE | Director | A | Stock Option (right to buy) | 242913 | $0.00 | 242,913.0000 | 7,443,577 | 9999.99% | 3.26% |
| Oct. 24, 2025 | Schneiderman Daniel H | Chief Financial Officer | A | Stock Option (right to buy) | 317266 | $0.00 | 317,266.0000 | 7,443,577 | 9999.99% | 4.26% |
| Oct. 24, 2025 | Novak Alfred J | Director | A | Stock Option (right to buy) | 42913 | $0.00 | 42,913.0000 | 7,443,577 | 9999.99% | 0.58% |
| Oct. 24, 2025 | Marques Tiago | Chief Executive Officer | A | Stock Option (right to buy) | 493341 | $0.00 | 493,341.0000 | 7,443,577 | 9999.99% | 6.63% |
| Oct. 24, 2025 | Leahy Emer | Director | A | Stock Option (right to buy) | 42913 | $0.00 | 42,913.0000 | 7,443,577 | 9999.99% | 0.58% |
| May 12, 2025 | Marques Tiago | Chief Executive Officer | S | Common Stock | 960 | $0.83 | 40,001.0000 | 2,211,207 | 2.34% | 0.04% |
| June 12, 2024 | Novak Alfred J | Director | A | Common Stock | 750 | $5.61 | 750.0000 | 1,042,479 | 9999.99% | 0.07% |
| June 13, 2024 | Novak Alfred J | Director | A | Common Stock | 2750 | $5.62 | 3,500.0000 | 1,042,479 | 366.67% | 0.26% |
| March 1, 2024 | Schneiderman Daniel H | Chief Financial Officer | A | Stock Option (right to buy) | 5927 | $0.00 | 5,927.0000 | 1,226,600 | 9999.99% | 0.48% |
| March 1, 2024 | Leahy Emer | Director | A | Stock Option (right to buy) | 7500 | $0.00 | 7,500.0000 | 1,226,600 | 9999.99% | 0.61% |
| March 1, 2024 | STEINMAN LAWRENCE | Director | A | Stock Option (right to buy) | 7500 | $0.00 | 7,500.0000 | 1,226,600 | 9999.99% | 0.61% |
| March 1, 2024 | Dumesnil Simon | Director | A | Stock Option (right to buy) | 7500 | $0.00 | 7,500.0000 | 1,226,600 | 9999.99% | 0.61% |
| March 1, 2024 | Schneiderman Daniel H | Chief Financial Officer | A | Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 1,226,600 | 9999.99% | 0.82% |
| March 1, 2024 | Currie Graeme Martin | Chief Development Officer | A | Stock Option (right to buy) | 5938 | $0.00 | 5,938.0000 | 1,226,600 | 9999.99% | 0.48% |
| March 1, 2024 | Novak Alfred J | Director | A | Stock Option (right to buy) | 5000 | $0.00 | 5,000.0000 | 1,226,600 | 9999.99% | 0.41% |
| March 1, 2024 | Marques Tiago | Chief Executive Officer | A | Stock Option (right to buy) | 11669 | $0.00 | 11,669.0000 | 1,226,600 | 9999.99% | 0.95% |
| March 1, 2024 | Marques Tiago | Chief Executive Officer | A | Stock Option (right to buy) | 15000 | $0.00 | 15,000.0000 | 1,226,600 | 9999.99% | 1.22% |
| March 1, 2024 | Marques Tiago | Chief Executive Officer | A | Stock Option (right to buy) | 11669 | $0.00 | 11,669.0000 | 1,226,600 | 9999.99% | 0.95% |
| March 1, 2024 | Dumesnil Simon | Director | A | Stock Option (right to buy) | 7500 | $0.00 | 7,500.0000 | 1,226,600 | 9999.99% | 0.61% |
| March 1, 2024 | Currie Graeme Martin | Chief Development Officer | A | Stock Option (right to buy) | 5938 | $0.00 | 5,938.0000 | 1,226,600 | 9999.99% | 0.48% |
| March 1, 2024 | Leahy Emer | Director | A | Stock Option (right to buy) | 7500 | $0.00 | 7,500.0000 | 1,226,600 | 9999.99% | 0.61% |
| March 1, 2024 | Schneiderman Daniel H | Chief Financial Officer | A | Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 1,226,600 | 9999.99% | 0.82% |
| March 1, 2024 | STEINMAN LAWRENCE | Director | A | Stock Option (right to buy) | 7500 | $0.00 | 7,500.0000 | 1,226,600 | 9999.99% | 0.61% |
| March 1, 2024 | Schneiderman Daniel H | Chief Financial Officer | A | Stock Option (right to buy) | 5927 | $0.00 | 5,927.0000 | 1,226,600 | 9999.99% | 0.48% |
| March 1, 2024 | Novak Alfred J | Director | A | Stock Option (right to buy) | 5000 | $0.00 | 5,000.0000 | 1,226,600 | 9999.99% | 0.41% |
| March 1, 2024 | Marques Tiago | Chief Executive Officer | A | Stock Option (right to buy) | 15000 | $0.00 | 15,000.0000 | 1,226,600 | 9999.99% | 1.22% |
| June 2, 2023 | STEINMAN LAWRENCE | Director | P | Common Stock | 30000 | $0.43 | 1,327,174.0000 | 1,303,652 | 2.31% | 2.30% |